FFA
ANAB icon

Farther Finance Advisors’s AnaptysBio ANAB Stock Holding History

Farther Finance Advisors’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$504K Buy
10,033
+9,638
+2,440% +$545K ﹤0.01% 1585
2026
Q2 		$26.6K Buy
395
+11
+3% +$667 ﹤0.01% 3761
2026
Q1 		$21.8K Hold
384
– – ﹤0.01% 3600
2025
Q4 		$18.6K Buy
384
+109
+40% +$4.25K ﹤0.01% 3503
2025
Q3 		$8.42K Sell
275
-62
-18% -$1.42K ﹤0.01% 3518
2025
Q2 		$7.48K Sell
337
-1,540
-82% -$32.2K ﹤0.01% 3211
2025
Q1 		$34.5K Buy
1,877
+1,858
+9,779% +$31K ﹤0.01% 2093
2024
Q4 		$252 Sell
19
-3
-14% -$73 ﹤0.01% 3600
2024
Q3 		$737 Sell
22
-7
-24% -$239 ﹤0.01% 3323
2024
Q2 		$714 Buy
29
+12
+71% +$279 ﹤0.01% 3177
2024
Q1 		$362 Hold
17
– – ﹤0.01% 3115
2023
Q4 		$364 Buy
17
+1
+6% +$17 ﹤0.01% 3077
2023
Q3 		$287 Hold
16
– – ﹤0.01% 2396
2023
Q2 		$325 Hold
16
– – ﹤0.01% 2263
2023
Q1 		$348 Hold
16
– – ﹤0.01% 2092
2022
Q4 		$496 Buy
+16
New +$452 ﹤0.01% 1830

Other funds holding ANAB

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Farther Finance Advisors's ANAB Position: Q3 2026 in Review

Farther Finance Advisors increased its AnaptysBio (ANAB) stake by 2,440% in Q3 2026, buying an estimated $545K and bringing the position to 10,033 shares worth $504K. The position accounts for ﹤0.01% of the portfolio, ranked #1585.

Farther Finance Advisors first reported a position in ANAB in Q4 2022 and has held it in 16 quarters since. 4 funds tracked by Wall St. Rank hold ANAB as of Q3 2026.

  • Farther Finance Advisors held 10,033 shares of AnaptysBio worth $504K as of Q3 2026.
  • Farther Finance Advisors bought 9,638 AnaptysBio shares in Q3 2026, an estimated $545K.
  • AnaptysBio made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #1585 holding.
  • Farther Finance Advisors first reported a position in AnaptysBio in Q4 2022 and has held it in 16 quarters since.
  • 4 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.